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ABSTRACT 
Objective: The purpose of this article was to prepare a new suitable dosage form of a traditional Thai antihypertensive herbal recipe (TTAH). All 
details in a preformulation study and physicochemical properties of the preparations were reported.  
Methods: Three different formulations were prepared and evaluated for their physicochemical properties. The preformulation studies were 
investigated including angle of repose, bulk density, tapped density, Carr’s index, and Hausner ratio before further formulation.The appropriate 
formulations were evaluated in their physicochemical properties such as weight variation, friability, thickness, hardness, disintegration time, and 
content uniformity.  
Results: The C1 capsule contained 400 mg of herbal powder was the best dosage form because of its good results in physicochemical properties 
evaluation such as weight variation (489.2±10.84 mg), disintegration time (4.02±1.20 min), and content uniformity (piperine98.38±1.78%, 
imperatorin98.60±1.08%, and pinostrobin102.44±1.29%).  
Conclusion: Considering to formulation of the TTAH as a capsule, a tablet, or a pill, many parameters were evaluated. Pills and tablets failed on at 
least one criterion, with difficulties in manufacturing or disintegrating ability being recorded. Capsules passed all tested criteria and became the 
formulation of choice for TTAH. 
Keywords: Traditional Thai antihypertensive herbal recipe, Physicochemical properties, Piperine, Imperatorin, Pinostrobin. 
 
INTRODUCTION 
Altering paradigm in natural product development, many research 
interests had been shifted to the ancient knowledge of medication 
such as, traditional medicine (TM), and alternative medicine. 
Additionally, the World Health Organization (WHO) indicates an 
important of such the knowledge and has been promoted the use of 
TM [1]. Since then, TM becomesa hot issue; a lot of effort is put into 
its marketing, inversely to its safety and quality assessment. In 2005, 
TDR regulation about chemistry-manufacturing-control (CMC) of TM 
was launched in order to provide a brief guideline for TM evaluation 
[2].In a quality control topic, it is indicated that a type of herbal 
product and its method of manufacture should be provided to 
support the clinical trial of TM. This report was associated with the 
data in the WHO guideline and ASEAN harmonization [3-4]. In 
Thailand, many traditional Thai medicine (TTM) has been widely 
used since now. In this article, a traditional Thai antihypertensive 
herbal recipe (TTAH), which was reported previously, was selected 
to be a model for formulation development. Recently, it was 
reported only a short discussion for TTAH preparation [5]. More 
details in the processes of formulation development and evaluation 
are needed [6]. Thus, an effort was made to prepare a suitable 
formulation of the antihypertensive herbal powder and to evaluate 
the physicochemical properties. All parameters were optimized in 
order to standardize the amount of active ingredients per dose, and 
to improve patient compliance. The information will be discussed in 
order to support the use of the TTAH and will be included in the 
chemistry-manufacturing-control (CMC) prior to clinical trials. 
MATERIALS AND METHODS 
Materials 
All herbal powders including Acanthusebracteatus, Aeglemarmelos, 
Boesenbergiapandurata, Cyperusrotundus, Pipernigrum, and 
Tinosporacrispa were purchased from CharoensukOsod, 
NakornPathom province, Thailand. Avicel PH 102, Aerosil®, and 
magnesium stearate were purchased from ChagzhouKaide Import 
and Export Co., Ltd., China. Polyvinyl pyrrolidone K 30 was 
purchased from Sigma-Aldrich®(USA).HPLC grade acetonitrile, 
water, and formic acid were purchased from B&J (Korea). Piperine, 
imperatorin, and pinostrobin standards were purchased from 
Sigma-Aldrich®
Herbal pill preparation 
(USA). Individual stock solutions (1.0 mg/ml) of 
three standards were prepared in acetonitrile-water (80:20) and 
filtered through 0.45 µm membrane filter. Working standards, 
piperine (0.25, 0.5, 2.5, 5, and 10 µg/ml), imperatorin (0.01, 0.05, 
0.1, 0.5, and 1 µg/ml), and pinostrobin (0.04, 0.2, 0.4, 2, and 4 µg/ml) 
were prepared by diluting the corresponding stock solution with 
acetonitrile-water (80:20) for LC-MS analysis. 
The herbal powders were tested by preformulation studies; angle of 
repose, bulk density, tapped density, Carr’s index, and Hausner ratio. 
As presented in the traditional method, the herbal powder was 
mixed with honey, rolled into a spherical shape, and cut into small 
pieces. The formulation which prepared by this method is 
represented by P1. 
Herbal tablet preparation 
Direct compression method  
Initially,herbal powder, avicel PH 102, and aerosil were mixed 
together by the geometric dilution method. Magnesium stearate was 
added and mixed together for 3 min. The ingredient ratios were 
shown in Table 1. The formulation which prepared by the direct 
compression method is represented by D1. The mixture powders were 
tested by preformulation studies; angle of repose, bulk density, tapped 
density, Carr’s index, and Hausnerratiobefore tablets compression.  
Wet granulation method  
Initially, herbal powder, avicel PH 102, povidone K30, and aerosil 
were mixed together by the geometric dilution method. Water was 
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then added into the mixture powders until a damp mass occurred, 
sieved through an 18-mesh sieve to produce granules. The granules 
were dried in hot air oven at 60 ◦
The granules were tested by preformulation studies; angle of repose, 
bulk density, tapped density, Carr’s index, and Hausner ratio before 
tablets compression. Then, the granules were compressed into 
tablets using a single punch tableting machine (Charatchai 
machinery Model: CMT 12, Thailand) with a die diameter of 10.3 
mm. The ingredients ratio is shown in Table 1 which designed as 
W1. The tablets were tested for the physicochemical properties such 
as, weight variation, friability, tablets thickness, tablets hardness, 
disintegration time, and content uniformity. 
C for 4 h. The dried granules were 
sieved again through a 20-mesh sieve and magnesium stearate was 
then added and mixed together for 3 min.  
Herbal capsule preparation 
The herbal powders were tested bypreformulation studies; angle of 
repose, bulk density, tapped density, Carr’s index, and Hausnerratio 
before filled into capsules. 400 mg of herbal powders were filled into 
capsule no.0 using the manual capsule filling machine. This 
formulation was represented by C1. The capsules were tested for the 
physicochemical properties such as, weight variation, disintegration 
time, and content uniformity. 
Preformulation studies 
Angle of repose  
The angle of repose was tested by the fixed funnel method. 5 g of 
powder mixture was poured into glass funnel. The lower tip of glass 
funnel was 5 cm height from the ground. The height (h) and radius 
(r) of pile were measured, and then calculated using the following 




θ = angle of repose (°
h = height (cm) 
) 
r = radius (cm) 
Bulk density 
7 g of powder mixture was accurately weighted and gently poured 
into 25 ml glass cylinder. The volume of powder mixture was 




m = mass (g) 
V0 = unsettled apparent volume (cm3
Tapped density 
) 
The glass cylinder with powder mixture from bulk density testing 
was used to test tapped density. It was tapped using tapped density 
tester (Erweka D-63150, Germany) for 1,250 strokes. The volume of 
tapped powder mixture was recorded and calculated using the 




m = mass (g) 
Vf  = final tapped volume (cm3
Carr’s index 
) 
Data from bulk density and tapped density testing were used for 







V0 = unsettled apparent volume (cm3
V
) 
f  = final tapped volume (cm3
Hausner ratio  
) 




V0 = unsettled apparent volume (cm3
V
) 
f  = final tapped volume (cm3
Physicochemical properties evaluation 
) 
All tablets, capsules, and pillswhich prepared by our colleagues were 
tested for their reasonable physicochemical properties. 
Weight variation 
Twenty tablets were individually accurately weighed. Each tablet 
weight was recorded. The weight variation was represented as 
mean±SD in mg.  
Friability 
The tablets had any dust removed before testing. Ten tablets were 
accurately weighed together, and friability was tested using a 
friability tester (K.S.L. Engineering, Thailand). After 4 min of rotation 
at 25 rpm, any loose dust from the tablets was removed before 
accurately weighing again. If friability was not more than 1.0% it 
was considered acceptable. The friability was calculated using the 









 = weight of tablets before test (g) 
after
Thickness 
= weight of tablets after test (g) 
Ten tablets were individually measured using the thickness tester 
(Mitutoyo Corp. Model: ID-C112TB Absolute, Japan).Results were 
reported as mean±SD in mm. 
Hardness 
Ten tablets were measured using a hardness tester (Erweka D-
63150 Model: TBH220TD, Germany). Results were reported 
mean±SD in kilopond (kP).  
Disintegration time (DT) 
Six tablets were tested by a disintegration tester (K.S.L. Engineering, 
Thailand) following the United State Pharmacopeial method, and 
water was used as the disintegration medium at 37 ◦
Content Uniformity 
C. DT of each 
tablet was recorded in minutes.If DT was not more than 30 minutes 
it was considered acceptable. 
To determine the amounts of three markers such as;piperine, 
imperatorin, and pinostrobin in the preparations, 10 samples of each 
TTAH dosage forms were crushed into small pieces (for any tablets 
or pills) andsonicated 5 times in 50 ml hexane for 20 min, pooled, 
and evaporated. The extracts were then analyzed using LC-MS 
method as described previously [7]. The uniformity of content was 
calculated separately to each analyzesand reported as mean±SD in 
percentages compared to the established average amounts of each 
markers in TTAH [6]. The average values were 1.43 %w/w, 0.05 
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%w/w, and 0.30 %w/w for piperine, imperatorin, and pinostrobin, 
respectively. 
 
Table 1: Formulation of herbal tablets/capsule/pill 
Ingredients D1 W1 C1 P1 
Herbal powder 500 500 400 300 
Avicel PH 102 143.5 130.5 - - 
Aerosil - 6.5 - - 
Magnesium stearate 6.5 6.5 - - 
Povidone K30 - 6.5 - - 
 
RESULTS AND DISCUSSION 
TTAH is the herbal product. According to CMC evidence needed to 
support clinical trials, the form of product and its method of 
manufacture are required. In this study, four preparations were 
prepared and compared in order to choose the suitable dosage 
forms for the recipe. The herbal powder and granule were evaluated 
in a pre-formulation study to optimize flow ability. The angle of 
repose results indicated flow ability of herbal powder was poor. This 
herbal powder was used directly in the preparation of P1 and C1. In 
D1, Avicel PH 102 and magnesium stearate were added into the 
formulation, the angle of repose of this formulation was not 
significantly different from P1 and C1.  
The flow ability was improved in W1 in which Aerosil®
 
 was added 
into the formulation. Flow abilities of the materials for the 
preparations were in the following order: W1 > D1 > P1 = C1 (Table 
2). The Carr’s index and Hausner ratio which used to predict flow 
characteristics were optimized.The results were correlated to the 
angle of repose results in which the herbal powder showed poor 
flow characteristics while the herbal granule showed excellent flow 
ability (Table 2). 
Table 2: Preformulation study 
Parameters  D1 W1 C1 P1 
Angle of repose 51 25 61 61 
Bulk density 0.39 0.43 0.34 0.34 
Tapped density 0.57 0.46 0.48 0.48 
Carr’s index 32 6 29 29 
Hausner ratio 1.48 1.07 1.41 1.41 
 
The physical appearances of tablet were brown, smooth and concave 
in shape, while pill was in a spherical shape. The physicochemical of 
all preparations was showed in Table 3 and Table 4. The weight 
variation of only D1, W1, and C1 was in acceptable range but W1 
showed the best result which indicated good uniformity of the 
preparation. Friability and hardness was tested only for D1, W1, and 
P1. It was found that the friability of all preparations was less than 
1%, revealing their stability against erosion during a process of drug 
shipping. The hardness results of these preparations were 
correlated to the friability results. In order to monitor the ability of 
dosage form to disintegrate before being dissolved and absorbed 
into the blood circulation, disintegration study must be performed. 
The result showed that the disintegration times of all preparations 
except P1 passed the criteria. It was reasonable since the hardness 
of P1 is 19.50 mm (Table 3). The content uniformity is the 
experiment to quantify the amount of markers in each dosage form 
and to assess its consistency. The standard value amounts of 
markers (piperine, imperatorin, and pinostrobin) were reported 
previously and can be used to calculate the content uniformity of the 
preparations. The relative standard deviation was calculated and it 
showed that the amount of markers in D1, W1, and C1 were 
consistent (Table 4). 
 
Table 3: Physicochemical properties evaluation of TTAH dosage forms 
Parameters D1 W1 C1 P1 
Weight variation (mg) 660.50 ± 8.21 658.28 ± 2.83 489.20 ± 10.84 314.11 ± 40.80 
Friability (%) 0.52 0.30 - 0.01 
Thickness (mm) 6.44 ± 0.09 6.85 ± 0.06 - 7.19 ± 0.14 
Hardness (mm) 6.01 ± 0.83 6.20 ± 0.70 - 19.50 ± 1.93 
Disintegration time (min) 15.94 ± 5.33 10.80 ± 2.69 4.02 ± 1.20 > 30 
 
Table 3: Content uniformity of reference standards in TTAH dosage forms 
Content uniformity (%) D1 W1 C1 P1 
Piperine 98.05 ± 2.76 98.23 ± 1.10 98.38 ± 1.78 95.12 ± 5.26 
Imperatorin 97.11 ± 2.14 98.51 ± 0.97 98.60 ± 1.08 96.11 ± 4.45 
Pinostrobin 102.25 ± 1.83 102.05 ± 0.63 102.44 ± 1.29 100.04 ± 4.33 
The C1 capsule contained 400 mg of herbal powder was the best dosage form because of its results in physicochemical properties evaluation such as 
weight variation (489.2±10.84 mg), disintegration time (4.02±1.20 min), and content uniformity (piperine98.38±1.78%, imperatorin98.60±1.08%, 
and pinostrobin102.44±1.29%). This dosage form is easy to prepare and might be practical in manufacturing scale. 
 
CONCLUSIONS 
When considering formulating the TTAH as a tablet, a capsule, or a 
pill, many parameters were evaluated. Pills failed on many criteria 
such as disintegration time and content uniformity.  
Although tablets preparing by wet granulation method was a good 
choice of preparation determining based on all evaluated 
parameters, but difficulties in manufacturing process was placed. 
Capsules passed all tested criteria and became the formulation of 
choice for TTAH. Finally, this data will be included as a part of the 
CMC evidence prior to clinical trials.  
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